2-Aminopurine

2-Aminopurine

SCHEMBL2787170

C=C1CC1.Nc1ncc2nc[nH]c2n1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
RXFP1 Q9HBX9 1/20 0.33
KDM4E B2RXH2 2/20 0.32
MAPT P10636 1/20 0.32
APEX1 P27695 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PDPK1 O15530 1/20 0.30
GDA Q9Y2T3 1/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30
HSD17B10 Q99714 1/20 0.30
PRKCI P41743 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Aminopurine SCHEMBL29901502 0.89 ALDH1A1 (0.48) ALDH1A1RXFP1KDM4EMAPTAPEX1
2-Aminopurine SCHEMBL5631 0.89 ALDH1A1 (0.48) ALDH1A1RXFP1KDM4EMAPTAPEX1
2-Aminopurine SCHEMBL28283405 0.87 ALDH1A1 (0.47) ALDH1A1RXFP1KDM4EMAPTAPEX1
2-Aminopurine SCHEMBL1528157 0.81 ALDH1A1 (0.42) ALDH1A1RXFP1KDM4EMAPTAPEX1
2-Aminopurine SCHEMBL10551243 0.81 ALDH1A1 (0.42) ALDH1A1RXFP1KDM4EMAPTAPEX1
2-Aminopurine SCHEMBL8343847 0.79 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTAPEX1
2-Aminopurine SCHEMBL383841 0.79 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTAPEX1
2-Aminopurine SCHEMBL4342851 0.79 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTAPEX1
2-Aminopurine SCHEMBL20305128 0.79 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTAPEX1
2-Aminopurine SCHEMBL9014624 0.79 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100279974-A1 Nucleosides With Non-Natural Bases as Anti-Viral Agents IDENIX PHARMACEUTICALS, INC. 2010-11-04 US disclosed
EP-1898934-A1 NUCLEOSIDES WITH NON-NATURAL BASES AS ANTI-VIRAL AGENTS Idenix (Cayman) Limited (KY) 2008-03-19 EP disclosed
WO-2007144686-A1 NUCLEOSIDES WITH NON-NATURAL BASES AS ANTI-VIRAL AGENTS IDENIX (CAYMAN) LIMITED (US) 2007-12-21 WO disclosed
US-20060040944-A1 5-Aza-7-deazapurine derivatives for treating Flaviviridae IDENIX PHARMACEUTICALS, INC. 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040944-A1 5-Aza-7-deazapurine derivatives for treating Flaviviridae TPMT, NUDT15, DUSP5 ALDH1A1 909/4885RXFP1 4733/4885KDM4E 312/4885
US-20100279974-A1 Nucleosides With Non-Natural Bases as Anti-Viral Agents PNP, NSUN2, NME2 ALDH1A1 3538/4885RXFP1 4588/4885KDM4E 2882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.